Preparation and in vitro activity of monoclonal antibody-pharmorubicin immunoconjugates

Yaoxue Xuebao

Volumn 31, Issue 8, 1996, Pages 632-636

  Xu, F H ^a,b   Jiang, X T ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Immunoconjugate; Monoclonal antibody; Pharmorubicin; Polyglutamic acid; Targeting cytotoxity

Indexed keywords

EPIRUBICIN; IMMUNOTOXIN; MONOCLONAL ANTIBODY;

ARTICLE; CELL CULTURE; HUMAN; LIVER TUMOR; PATHOLOGY;

ANTIBODIES, MONOCLONAL; EPIRUBICIN; HUMANS; IMMUNOTOXINS; LIVER NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030309847     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kaneko T, Willner D, Monkovic I et al. New hydrazone derivatives of adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity. Bioconjug Chem, 1991, 2:133
2. Shen WC, Ryser HJP. Cis-aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem Biophy Res Commun, 1981, 102:1048
3. Greenfield RS, Kaneko T, Daues A et al. Evaluation in vitro of adriamycin immunoconjugate synthesized using an acid-sensitive hydrazone linker. Cancer Res, 1990, 50:6600
4. Braslawsky GR, Edson MA, Pearce W et al. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing. Cancer Res, 1990, 50:6608
5. Yang HM, Reisfeld RA. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice. Proc Natl Acad Sci USA, 1988, 85:1189
6. Galun E, Shouval D, Adler R et al. The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma. Hepatology, 1990, 11:578
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72:248
8. Hurwitz E, Waron R, Bernstein A et al. The in vivo effect of chemotherapeutic drug-antibody conjugates in two murine experimental tumor systems. Int J Cancer, 1978, 21:747
9. Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res, 1990, 50(Suppl):814
10. Osdol W, Fujimori K, Weinstein N. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier". Cancer Res, 1991, 51:4776